Is this your brand? Sign in to claim ownership.

Sign in to claim this brand

Botiss Biomaterials GmbH

US

Last updated May 27, 2026

What Botiss Biomaterials GmbH makes

Botiss Biomaterials GmbH produces dental bone matrix implants derived from animal sources, designed for bone regeneration in oral and maxillofacial procedures. Their portfolio also includes collagen-based dental regeneration membranes, intended to support tissue healing and integration in implant sites.

These devices are classified as Class II under regulatory frameworks, with authorisations granted through FDA 510(k) and UDI listings. The company is based in the US and operates within these regulatory pathways for its dental biomaterials.

Written from this company's registered devices by an AI model, and not verified by a human reviewer.

Frequently asked questions

What types of medical devices does Botiss Biomaterials GmbH manufacture?

Botiss Biomaterials GmbH specializes in dental biomaterials, specifically animal-derived bone matrix implants and collagen-based dental regeneration membranes. These devices are primarily used in oral and maxillofacial procedures to support bone regeneration and tissue healing, such as during dental implant placements.

Where is Botiss Biomaterials GmbH based?

Botiss Biomaterials GmbH is based in the United States. The company’s operations and regulatory submissions are aligned with US-based frameworks, including FDA pathways for its dental biomaterials.

Which regulatory registries or databases list Botiss Biomaterials GmbH’s devices?

Botiss Biomaterials GmbH’s devices are listed in the FDA’s 510(k) premarket notification database and the FDA’s Unique Device Identifier (UDI) system. These registries reflect the regulatory authorisation process for its Class II dental biomaterials.

How are Botiss Biomaterials GmbH’s devices classified under regulatory frameworks?

Botiss Biomaterials GmbH’s devices are classified as Class II under regulatory frameworks. This classification applies to dental bone matrix implants and collagen membranes, which require premarket notification (510(k)) to demonstrate substantial equivalence to legally marketed predicate devices before commercial distribution.

AI-generated from registry data and not verified by a human reviewer.

Information

Country
US
Address
—
Website
botiss.com
LinkedIn
—
Facebook
—
Phone
+49337698841985
PRRC Contact
—
EUDAMED SRN
—
FDA FEI Number
—
DUNS Number
341685939

Catalogue (23)

DeviceModel / ReferenceRegistriesClassStatus
cerabone® MEUS-1522
FDA UDI
Class IIActive
Straumann® Jason® membrane BS-683040
FDA UDI
Class IIActive
cerabone® MEUS-1525
FDA UDI
Class IIActive
Straumann® cerabone® BS-1522
FDA UDI
Class IIActive
cerabone® MEUS-1521
FDA UDI
Class IIActive
cerabone® MEUS-1512
FDA UDI
Class IIActive
cerabone® MEUS-1520
FDA UDI
Class IIActive
Straumann® cerabone® BS-1512
FDA UDI
Class IIActive
Straumann® Jason® membrane BS-682030
FDA UDI
Class IIActive
Jason® membrane MEUS-681520
FDA UDI
Class IIActive
Straumann® cerabone® BS-1525
FDA UDI
Class IIActive
Straumann® cerabone® BS-1520
FDA UDI
Class IIActive
Jason® membrane MEUS-682030
FDA UDI
Class IIActive
cerabone® MEUS-1510
FDA UDI
Class IIActive
Straumann® cerabone® BS-1515
FDA UDI
Class IIActive
Jason® membrane MEUS-683040
FDA UDI
Class IIActive
Straumann® cerabone® BS-1510
FDA UDI
Class IIActive
Straumann® Jason® membrane BS-681520
FDA UDI
Class IIActive
cerabone® MEUS-1511
FDA UDI
Class IIActive
Straumann® cerabone® BS-1521
FDA UDI
Class IIActive
cerabone® MEUS-1515
FDA UDI
Class IIActive
Straumann® cerabone® BS-1511
FDA UDI
Class IIActive
Jason membrane K242817
FDA 510(k)
Class IIActive

Related Companies

Authorised Representatives

No authorised representatives on record.

Importers

Not available yet.

Notified Bodies

Not available yet.

Authorities

Not available yet.

FDA Establishments (1)

Establishments registered with the FDA under this company group, matched by name.

  • Botiss Biomaterials Gmbh Zossen Brandenburg · DE FEI 3014206569